Current News

Print version | PDF version | Send article | RSS feed

Akela Pharma awarded development contract from Pear Tree Pharmaceuticals, Inc. at its PharmaForm subsidiary

16 Jun 2008 - Akela Pharma Inc. announced that it has been awarded a development contract from Pear Tree Pharmaceuticals, Inc. at its PharmaForm subsidiary located in Austin, Texas, for the development of two different drug products for treatment of atrophic vaginitis. PharmaForm will develop the drug products to deliver Pear Tree's confidential drug substances to the vaginal cavity.
 
"We are proud to have the opportunity to work on the development of this new therapy with Pear Tree Pharmaceuticals. We believe that PharmaForm's know how and experience delivering novel and innovative formulation and product development solutions to the pharmaceutical industry, in particular vaginal delivery, will provide Pear Tree Pharmaceuticals with a fast and efficient development process" said Dr. Michael Crowley, Vice President, Business Development of PharmaForm.
 
"We are pleased to be working with PharmaForm on these important products. We believe PharmaForm's recognized expertise in drug product development and delivery to the vaginal cavity will help us accelerate our program strategies" mentioned Stephen C. Rocamboli, President of Pear Tree Pharmaceuticals, Inc.